Axonal transport deficits in multiple sclerosis: spiraling into the abyss.
The transport of mitochondria and other cellular components along the axonal microtubule cytoskeleton plays an essential role in neuronal survival. Defects in this system have been linked to a large number of neurological disorders. In multiple sclerosis (MS) and associated models such as experimental autoimmune encephalomyelitis (EAE), alterations in axonal transport have been shown to exist before neurodegeneration occurs. Genome-wide association (GWA) studies have linked several motor proteins to MS susceptibility, while neuropathological studies have shown accumulations of proteins and organelles suggestive for transport deficits. A reduced effectiveness of axonal transport can lead to neurodegeneration through inhibition of mitochondrial motility, disruption of axoglial interaction or prevention of remyelination. In MS, demyelination leads to dysregulation of axonal transport, aggravated by the effects of TNF-alpha, nitric oxide and glutamate on the cytoskeleton. The combined effect of all these pathways is a vicious cycle in which a defective axonal transport system leads to an increase in ATP consumption through loss of membrane organization and a reduction in available ATP through inhibition of mitochondrial transport, resulting in even further inhibition of transport. The persistent activity of this positive feedback loop contributes to neurodegeneration in MS.
Department Of Neurology, Erasmus MC Rotterdam, Rotterdam, The Netherlands. r.vandenberg@erasmusmc.nl.
Robert
0000-0003-4806-3599
R
van den Berg
Cell Biology, Utrecht University, Utrecht, The Netherlands.
Casper C
CC
Hoogenraad
Department Of Neurology, Erasmus MC Rotterdam, Rotterdam, The Netherlands.
Rogier Q
RQ
Hintzen
D000818:Animals; D001370:Axonal Transport / Q000502:physiology*; D006801:Humans; D009103:Multiple Sclerosis / Q000378:metabolism*
Axonal transport; Dynein; Intracellular transport; Kinesin; Microtubule; Mitochondrial transport; Neurodegeneration